Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to include 3 additional interventions/treatments and has moved to revision v2.10.0, replacing the previous v2.9.7.SummaryDifference0.8%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check24 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'Drug Information available for: Nivolumab Relatlimab FDA Drug and Device Resources Show less'. This change indicates an update in the drug information available on the webpage.SummaryDifference26%
Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.